missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human UACA (aa 1067-1167) Control Fragment Recombinant Protein
Click to view available options
Quantité:
100 μl
Conditionnement:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (81%), Rat (81%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-59560 (PA5-59560. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Regulates APAF1 expression and plays an important role in the regulation of stress-induced apoptosis. Promotes apoptosis by regulating three pathways, apoptosome up-regulation, LGALS3/galectin-3 down-regulation and NF-kappa-B inactivation. Regulates the redistribution of APAF1 into the nucleus after proapoptotic stress. Down-regulates the expression of LGALS3 by inhibiting NFKB1.
Spécification
Spécification
| Numéro d’adhésion | Q9BZF9 |
| Concentration | ≥5.0 mg/mL |
| À utiliser avec (application) | Blocking Assay, Control |
| Formule | 1 M urea, PBS with no preservative; pH 7.4 |
| Identification génétique (Entrez) | 55075 |
| Nom | Human UACA (aa 1067-1167) Control Fragment |
| Quantité | 100 μl |
| État réglementaire | RUO |
| Alias de gène | 2700059D02Rik; beta-actin binding protein betaCAP73; beta-actin-binding protein; BetaCAP73; Kiaa1561; nuclear membrane binding protein; nuclear membrane binding protein NUCLING; nuclear membrane-binding protein; Nucling; RGD1560011; Uaca; uveal autoantigen; uveal autoantigen with coiled coil domains and ankyrin repeats; uveal autoantigen with coiled-coil domains and ankyrin repeats; Uveal autoantigen with coiled-coil domains and ankyrin repeats protein |
| Nom usuel | UACA |
| Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu